Description
This peptide fragment of the soluble IL-6 receptor binds IL-6 weakly but does not display significant downstream signaling effects. This peptide may be used to measure presence of IL-6 or immunomodulation by other compounds.
| Product Unit Size | Cost | Quantity | Stock |
|---|
This peptide fragment of the soluble IL-6 receptor binds IL-6 weakly but does not display significant downstream signaling effects. This peptide may be used to measure presence of IL-6 or immunomodulation by other compounds.
| Purity | ≥95% |
|---|---|
| Formula | C51H85N13O21 |
| Formula Wt. | 1216.32 |
| Synonym | IL-6R |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Bosze S, Hudecz F, Igaz P, et al. Interleukin-6 N-terminal peptides modulate the expression of junB protooncogene and the production of fibrinogen in HepG2 cells. Biol Chem. 2003 Mar;384(3):409-21. PMID: 12715892.
Mycotoxin produced by species of Fusarium; pote...
Reversible DNMT1-selective inhibitor
Peptide, derived from egg outer envelope; K+ ch...
Resveratrol prodrug; potential SIRT1 activator....
Multikinase inhibitor.
Pyrimidine nucleoside (cytidine) analog; DNA ch...
Na+ channel blocker.
Glucocorticoid
Benzisoxazole phenylethanone; D2 and 5-HT2A ant...
COVID-19 research
Found in Aristolochia and Radix; potential PLA2...
Inhibitor of PI3K.
PI3K and HDAC inhibitor.
AhR agonist.
p110δ PI3K inhibitor.
Cytarabine derivative, nucleoside (cytosine) an...
Phallotoxin found in Amanita phalloides; microt...
GABA potentiator, voltage-gated Na+ and ATP-sen...
Dopamine reuptake inhibitor (DRI).
5-HT1B/1D agonist.